Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1022820160070010001
Journal of Multiple Sclerosis and Neuroimmunology
2016 Volume.7 No. 1 p.1 ~ p.8
What¡¯s New in 2014-2015: Neuromyelitis Optica
Lee Sun-Ah

Kim Jee-Eun
Abstract
Neuromyelitis optica (NMO) is another idiopathic, severe demyelinating disease that preferentially involves optic nerves and spinal cord. NMO has been frequently misclassified as multiple sclerosis (MS) previously due to its similar clinical presentation. However, growing knowledge of NMO enables clinician to differentiate it from MS by clinical, laboratory (especially by presence of aquaporin- 4 antibodies), neuroimaging, and pathological characteristics. In 2014-2015, there were striking efforts to integrate the knowledge of NMO and to suggest more sensitive and accurate diagnostic criteria by international panel. In this review, we summarized recently obtained knowledge of NMO focusing its clinical and laboratory findings, therapy and highlighted the new diagnostic criteria for NMO, 2015.
KEYWORD
Neuromyelitis optica, Diagnostic criteria, Biomarkers, Therapy
FullTexts / Linksout information
Listed journal information